Two Sigma Investments
AUTL

Two Sigma Investments’s Autolus Therapeutics AUTL Stock Holding History

Two Sigma Investments’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-172,143
Closed -$281K – 4068
2025
Q3 		$281K Buy
172,143
+25,346
+17% +$49.5K ﹤0.01% 3242
2025
Q2 		$335K Sell
146,797
-248,646
-63% -$411K ﹤0.01% 2750
2025
Q1 		$613K Sell
395,443
-511,324
-56% -$1.04M ﹤0.01% 2431
2024
Q4 		$2.13M Buy
906,767
+174,485
+24% +$590K ﹤0.01% 1669
2024
Q3 		$2.66M Sell
732,282
-273,634
-27% -$1.09M 0.01% 1496
2024
Q2 		$3.5M Buy
1,005,916
+777,074
+340% +$3.35M 0.01% 1184
2024
Q1 		$1.46M Sell
228,842
-28,414
-11% -$177K ﹤0.01% 1718
2023
Q4 		$1.66M Buy
257,256
+41,561
+19% +$159K ﹤0.01% 1746
2023
Q3 		$503K Sell
215,695
-93,092
-30% -$265K ﹤0.01% 2277
2023
Q2 		$735K Buy
308,787
+215,348
+230% +$511K ﹤0.01% 2132
2023
Q1 		$172K Buy
93,439
+59,739
+177% +$117K ﹤0.01% 2589
2022
Q4 		$64K Buy
+33,700
New +$85.2K ﹤0.01% 2564
2021
Q2 		– Sell
-77,140
Closed -$442K – 4031
2021
Q1 		$442K Buy
+77,140
New +$571K ﹤0.01% 3044
2020
Q4 		– Sell
-33,177
Closed -$386K – 3324
2020
Q3 		$386K Buy
+33,177
New +$481K ﹤0.01% 2422

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Two Sigma Investments's AUTL Position: Q4 2025 in Review

Two Sigma Investments sold out of Autolus Therapeutics (AUTL) in Q4 2025, closing a stake of 172,143 shares — an estimated $281K sold.

Two Sigma Investments first reported a position in AUTL in Q3 2020 and held it in 14 quarters. The position peaked at $3.5M in Q2 2024. 89 funds tracked by Wall St. Rank hold AUTL as of Q4 2025.

  • Two Sigma Investments reported no remaining Autolus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 172,143 Autolus Therapeutics shares in Q4 2025, an estimated $281K.
  • Two Sigma Investments first reported a position in Autolus Therapeutics in Q3 2020 and held it in 14 quarters.
  • Two Sigma Investments's Autolus Therapeutics position peaked at $3.5M in Q2 2024.
  • 89 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.